David Patience

David Patience is a declared insider at 2 companies; the most frequent names are Accelerate Diagnostics, Inc and TriSalus Life Sciences, Inc. In total, 22 filings cover trades dated from 13 April 2023 to 1 July 2026.

The open-market side counts 1 purchase for €13k alongside 4 sales for €2,183. The net balance comes to €10k on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 4 share grants and 13 option exercises. Since January 2026: 1 purchase and no sales on the market.

The newest entry dates from 6 July 2026: a share grant of €57k, in TriSalus Life Sciences, Inc. The last purchase on record was published on 23 February 2026, which is 237 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.